Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 426 entries
Sorted by: Best Match Show Resources per page
Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study.

Stem cells international

Ahmed Nel-M, Murakami M, Hirose Y, Nakashima M.
PMID: 27403169
Stem Cells Int. 2016;2016:8102478. doi: 10.1155/2016/8102478. Epub 2016 Jun 14.

The secretome obtained from stem cell cultures contains an array of neurotrophic factors and cytokines that might have the potential to treat neurodegenerative conditions. Alzheimer's disease (AD) is one of the most common human late onset and sporadic neurodegenerative...

Cite
Ahmed Nel-M, Murakami M, Hirose Y, et al. Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study. Stem Cells Int. 2016;2016:8102478doi: 10.1155/2016/8102478.
Ahmed, N. e. l. -. M., Murakami, M., Hirose, Y., & Nakashima, M. (2016). Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study. Stem cells international, 20168102478. https://doi.org/10.1155/2016/8102478
Ahmed, Nermeen El-Moataz Bellah, et al. "Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study." Stem cells international vol. 2016 (2016): 8102478. doi: https://doi.org/10.1155/2016/8102478
Ahmed Nel-M, Murakami M, Hirose Y, Nakashima M. Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study. Stem Cells Int. 2016;2016:8102478. doi: 10.1155/2016/8102478. Epub 2016 Jun 14. PMID: 27403169; PMCID: PMC4923581.
Copy Download .nbib Format: NLM
[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction].

Kardiologiia

Kobalava ZD, Pavlikova EP, Averkov OA, Merai I, Babaeva LA, Amirbegishvili IA, Kotovskaya YV, Moiseev VS.
PMID: 28294911
Kardiologiia. 2015 Jul;55(7):14-25.

Simultaneous inhibition of the renin-angiotensin-aldosterone system and the system of degradation of natriuretic peptides can potentially provide unique therapeutic effects in patients with chronic heart failure (CHF) with reduced ejection fraction (EF). Aim of this study was to assess...

Cite
Kobalava ZD, Pavlikova EP, Averkov OA, et al. [First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. Kardiologiia. 2015;55(7):14-25
Kobalava, Z. D., Pavlikova, E. P., Averkov, O. A., Merai, I., Babaeva, L. A., Amirbegishvili, I. A., Kotovskaya, Y. V., & Moiseev, V. S. (2015). [First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. Kardiologiia, 55(7), 14-25.
Kobalava, Zh D, et al. "[First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]." Kardiologiia vol. 55,7 (2015): 14-25.
Kobalava ZD, Pavlikova EP, Averkov OA, Merai I, Babaeva LA, Amirbegishvili IA, Kotovskaya YV, Moiseev VS. [First Experience of Clinical Application of LCZ696 an AT1-angiotensin Receptors and Neprilysin Inhibitor in Patients With Chronic Heart Failure and Reduced Ejection Fraction]. Kardiologiia. 2015 Jul;55(7):14-25. Russian. PMID: 28294911.
Copy Download .nbib Format: NLM
Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente.

JAMA cardiology

Yancy CW, Fonarow GC.
PMID: 27654980
JAMA Cardiol. 2016 Dec 01;1(9):973. doi: 10.1001/jamacardio.2016.3534.

No abstract available.

Cite
Yancy CW, Fonarow GC. Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente. JAMA Cardiol. 2016;1(9):973doi: 10.1001/jamacardio.2016.3534.
Yancy, C. W., & Fonarow, G. C. (2016). Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente. JAMA cardiology, 1(9), 973. https://doi.org/10.1001/jamacardio.2016.3534
Yancy, Clyde W, and Fonarow, Gregg C. "Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente." JAMA cardiology vol. 1,9 (2016): 973. doi: https://doi.org/10.1001/jamacardio.2016.3534
Yancy CW, Fonarow GC. Angiotensin Receptor Neprilysin Inhibitor Use Urgency: Festina Lente. JAMA Cardiol. 2016 Dec 01;1(9):973. doi: 10.1001/jamacardio.2016.3534. PMID: 27654980.
Copy Download .nbib Format: NLM
Role of amyloid precursor protein (APP) in regulation of neuronal genes.

SpringerPlus

Nalivaeva NN.
PMID: 27386202
Springerplus. 2015 Jun 12;4:L40. doi: 10.1186/2193-1801-4-S1-L40. eCollection 2015.

No abstract available.

Cite
Nalivaeva NN. Role of amyloid precursor protein (APP) in regulation of neuronal genes. Springerplus. 2015;4:L40doi: 10.1186/2193-1801-4-S1-L40.
Nalivaeva, N. N. (2015). Role of amyloid precursor protein (APP) in regulation of neuronal genes. SpringerPlus, 4L40. https://doi.org/10.1186/2193-1801-4-S1-L40
Nalivaeva, Natalia N. "Role of amyloid precursor protein (APP) in regulation of neuronal genes." SpringerPlus vol. 4 (2015): L40. doi: https://doi.org/10.1186/2193-1801-4-S1-L40
Nalivaeva NN. Role of amyloid precursor protein (APP) in regulation of neuronal genes. Springerplus. 2015 Jun 12;4:L40. doi: 10.1186/2193-1801-4-S1-L40. eCollection 2015. PMID: 27386202; PMCID: PMC4798292.
Copy Download .nbib Format: NLM
Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas.

Korean journal of pathology

Park JH, Lee C, Suh JH, Moon KC.
PMID: 23323104
Korean J Pathol. 2012 Dec;46(6):541-7. doi: 10.4132/KoreanJPathol.2012.46.6.541. Epub 2012 Dec 26.

BACKGROUND: Clear cell papillary renal cell carcinoma (CCPRCC) is a recently established subtype of renal epithelial tumor. The aim of this study was to identify the diagnostic criteria of CCPRCC with an emphasis on immunohistochemical studies, and to report...

Cite
Park JH, Lee C, Suh JH, et al. Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas. Korean J Pathol. 2012;46(6):541-7doi: 10.4132/KoreanJPathol.2012.46.6.541.
Park, J. H., Lee, C., Suh, J. H., & Moon, K. C. (2012). Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas. Korean journal of pathology, 46(6), 541-7. https://doi.org/10.4132/KoreanJPathol.2012.46.6.541
Park, Jeong Hwan, et al. "Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas." Korean journal of pathology vol. 46,6 (2012): 541-7. doi: https://doi.org/10.4132/KoreanJPathol.2012.46.6.541
Park JH, Lee C, Suh JH, Moon KC. Clear cell papillary renal cell carcinoma: a report of 15 cases including three cases of concurrent other-type renal cell carcinomas. Korean J Pathol. 2012 Dec;46(6):541-7. doi: 10.4132/KoreanJPathol.2012.46.6.541. Epub 2012 Dec 26. PMID: 23323104; PMCID: PMC3540331.
Copy Download .nbib Format: NLM
Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling.

Frontiers in physiology

Hicks DA, Nalivaeva NN, Turner AJ.
PMID: 22737128
Front Physiol. 2012 Jun 22;3:189. doi: 10.3389/fphys.2012.00189. eCollection 2012.

Lipid rafts are membrane domains, more ordered than the bulk membrane and enriched in cholesterol and sphingolipids. They represent a platform for protein-lipid and protein-protein interactions and for cellular signaling events. In addition to their normal functions, including membrane...

Cite
Hicks DA, Nalivaeva NN, Turner AJ. Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front Physiol. 2012;3:189doi: 10.3389/fphys.2012.00189.
Hicks, D. A., Nalivaeva, N. N., & Turner, A. J. (2012). Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Frontiers in physiology, 3189. https://doi.org/10.3389/fphys.2012.00189
Hicks, David A, et al. "Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling." Frontiers in physiology vol. 3 (2012): 189. doi: https://doi.org/10.3389/fphys.2012.00189
Hicks DA, Nalivaeva NN, Turner AJ. Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front Physiol. 2012 Jun 22;3:189. doi: 10.3389/fphys.2012.00189. eCollection 2012. PMID: 22737128; PMCID: PMC3381238.
Copy Download .nbib Format: NLM
Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice.

Frontiers in aging neuroscience

Mainardi M, Di Garbo A, Caleo M, Berardi N, Sale A, Maffei L.
PMID: 24478697
Front Aging Neurosci. 2014 Jan 23;6:1. doi: 10.3389/fnagi.2014.00001. eCollection 2014.

Brain aging is characterized by global changes which are thought to underlie age-related cognitive decline. These include variations in brain activity and the progressive increase in the concentration of soluble amyloid-β (Aβ) oligomers, directly impairing synaptic function and plasticity...

Cite
Mainardi M, Di Garbo A, Caleo M, et al. Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice. Front Aging Neurosci. 2014;6:1doi: 10.3389/fnagi.2014.00001.
Mainardi, M., Di Garbo, A., Caleo, M., Berardi, N., Sale, A., & Maffei, L. (2014). Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice. Frontiers in aging neuroscience, 61. https://doi.org/10.3389/fnagi.2014.00001
Mainardi, Marco, et al. "Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice." Frontiers in aging neuroscience vol. 6 (2014): 1. doi: https://doi.org/10.3389/fnagi.2014.00001
Mainardi M, Di Garbo A, Caleo M, Berardi N, Sale A, Maffei L. Environmental enrichment strengthens corticocortical interactions and reduces amyloid-β oligomers in aged mice. Front Aging Neurosci. 2014 Jan 23;6:1. doi: 10.3389/fnagi.2014.00001. eCollection 2014. PMID: 24478697; PMCID: PMC3899529.
Copy Download .nbib Format: NLM
Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

American journal of neurodegenerative disease

O'Hagan TS, Wharton W, Kehoe PG.
PMID: 23383397
Am J Neurodegener Dis. 2012;1(3):266-79. Epub 2012 Nov 18.

Interactions between oestrogen and the renin angiotensin system (RAS) are reviewed and explored from the perspective where these interactions may modulate risk of developing Alzheimer's disease (AD). AD is more prevalent in women than men, partly attributed to women's...

Cite
O'Hagan TS, Wharton W, Kehoe PG. Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease. Am J Neurodegener Dis. 2012;1(3):266-79
O'Hagan, T. S., Wharton, W., & Kehoe, P. G. (2012). Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease. American journal of neurodegenerative disease, 1(3), 266-79.
O'Hagan, Thomas Simon, et al. "Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease." American journal of neurodegenerative disease vol. 1,3 (2012): 266-79.
O'Hagan TS, Wharton W, Kehoe PG. Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease. Am J Neurodegener Dis. 2012;1(3):266-79. Epub 2012 Nov 18. PMID: 23383397; PMCID: PMC3560469.
Copy Download .nbib Format: NLM
Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease.

Frontiers in aging neuroscience

Tampellini D, Gouras GK.
PMID: 20725518
Front Aging Neurosci. 2010 May 21;2. doi: 10.3389/fnagi.2010.00013. eCollection 2010.

beta-Amyloid peptide accumulation plays a central role in the pathogenesis of Alzheimer's disease. Aberrant beta-amyloid buildup in the brain has been shown to be present both in the extracellular space and within neurons. Synapses are important targets of beta-amyloid,...

Cite
Tampellini D, Gouras GK. Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease. Front Aging Neurosci. 2010;2doi: 10.3389/fnagi.2010.00013.
Tampellini, D., & Gouras, G. K. (2010). Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease. Frontiers in aging neuroscience, 2. https://doi.org/10.3389/fnagi.2010.00013
Tampellini, Davide, and Gouras, Gunnar K. "Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease." Frontiers in aging neuroscience vol. 2 (2010). doi: https://doi.org/10.3389/fnagi.2010.00013
Tampellini D, Gouras GK. Synapses, synaptic activity and intraneuronal abeta in Alzheimer's disease. Front Aging Neurosci. 2010 May 21;2. doi: 10.3389/fnagi.2010.00013. eCollection 2010. PMID: 20725518; PMCID: PMC2912028.
Copy Download .nbib Format: NLM
American Heart Association 2018 Scientific Sessions.

P & T : a peer-reviewed journal for formulary management

Alexander W.
PMID: 30766010
P T. 2019 Jan;44(2):48-63.

We report on sessions on the dapagliflozin effect on cardiovascular events; angiotensin receptor-neprilysin inhibition for acute decompensated heart failure; rivaroxaban's effect on thromboembolic events with heart failure, sinus rhythm, and coronary disease; trial results on the withdrawal of pharmacological...

Cite
Alexander W. American Heart Association 2018 Scientific Sessions. P T. 2019;44(2):48-63
Alexander, W. (2019). American Heart Association 2018 Scientific Sessions. P & T : a peer-reviewed journal for formulary management, 44(2), 48-63.
Alexander, Walter. "American Heart Association 2018 Scientific Sessions." P & T : a peer-reviewed journal for formulary management vol. 44,2 (2019): 48-63.
Alexander W. American Heart Association 2018 Scientific Sessions. P T. 2019 Jan;44(2):48-63. PMID: 30766010; PMCID: PMC6355049.
Copy Download .nbib Format: NLM
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.

The New England journal of medicine

[No authors listed]
PMID: 30767714
N Engl J Med. 2019 Mar 14;380(11):1090. doi: 10.1056/NEJMx190009. Epub 2019 Feb 15.

No abstract available.

Cite
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019;380(11):1090doi: 10.1056/NEJMx190009.
(2019). Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. The New England journal of medicine, 380(11), 1090. https://doi.org/10.1056/NEJMx190009
"Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure." The New England journal of medicine vol. 380,11 (2019): 1090. doi: https://doi.org/10.1056/NEJMx190009
Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 Mar 14;380(11):1090. doi: 10.1056/NEJMx190009. Epub 2019 Feb 15. PMID: 30767714.
Copy Download .nbib Format: NLM
Degradation of amyloid β peptide by neprilysin expressed from Borna disease virus vector.

Microbiology and immunology

Sakai M, Ueda S, Daito T, Asada-Utsugi M, Komatsu Y, Kinoshita A, Maki T, Kuzuya A, Takahashi R, Makino A, Tomonaga K.
PMID: 29771464
Microbiol Immunol. 2018 May 17; doi: 10.1111/1348-0421.12602. Epub 2018 May 17.

Accumulation of amyloid β (Aβ40 and Aβ42) in the brain is a characteristic of Alzheimer's disease (AD). Because neprilysin (NEP) is a major Aβ-degrading enzyme, NEP delivery in the brain is a promising gene therapy for AD. Borna disease...

Cite
Sakai M, Ueda S, Daito T, et al. Degradation of amyloid β peptide by neprilysin expressed from Borna disease virus vector. Microbiol Immunol. 2018;doi: 10.1111/1348-0421.12602.
Sakai, M., Ueda, S., Daito, T., Asada-Utsugi, M., Komatsu, Y., Kinoshita, A., Maki, T., Kuzuya, A., Takahashi, R., Makino, A., & Tomonaga, K. (2018). Degradation of amyloid β peptide by neprilysin expressed from Borna disease virus vector. Microbiology and immunology, . https://doi.org/10.1111/1348-0421.12602
Sakai, Madoka, et al. "Degradation of amyloid β peptide by neprilysin expressed from Borna disease virus vector." Microbiology and immunology vol. (2018). doi: https://doi.org/10.1111/1348-0421.12602
Sakai M, Ueda S, Daito T, Asada-Utsugi M, Komatsu Y, Kinoshita A, Maki T, Kuzuya A, Takahashi R, Makino A, Tomonaga K. Degradation of amyloid β peptide by neprilysin expressed from Borna disease virus vector. Microbiol Immunol. 2018 May 17; doi: 10.1111/1348-0421.12602. Epub 2018 May 17. PMID: 29771464.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 426 entries